Literature DB >> 19359411

Impaired development of human Th1 cells in patients with deficient expression of STAT4.

Hua-Chen Chang1, Ling Han, Ritobrata Goswami, Evelyn T Nguyen, David Pelloso, Michael J Robertson, Mark H Kaplan.   

Abstract

IL-12 activates STAT4, which is a critical regulator of inflammation and T helper type I (Th1) lineage development in murine systems. The requirement for STAT4 in the generation of human Th1 cells has not been examined thoroughly. Compared with control Th1 cultures, expression of the Th1 genes IFNgamma, IL-12Rbeta2, and TNFalpha is greatly reduced in Th1 cultures of CD4 T cells isolated from lymphoma patients after autologous stem cell transplantation who have acquired STAT4 deficiency. Moreover, IL-4 and IL-5 production is increased in patient Th1 cultures though there are no defects in the development of Th2 cells. Reconstitution of STAT4 in patient T cells allowed recovery of IFNgamma and IL-12Rbeta2 expression, whereas ectopic expression of IL-12Rbeta2 did not rescue STAT4 expression, and increased IFNgamma production only to levels intermediate between control and patient samples. These results demonstrate that, as in murine systems, STAT4 is required for optimal human Th1 lineage development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19359411      PMCID: PMC2700324          DOI: 10.1182/blood-2008-09-179820

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

1.  A novel transcription factor, T-bet, directs Th1 lineage commitment.

Authors:  S J Szabo; S T Kim; G L Costa; X Zhang; C G Fathman; L H Glimcher
Journal:  Cell       Date:  2000-03-17       Impact factor: 41.582

2.  Activated STAT4 has an essential role in Th1 differentiation and proliferation that is independent of its role in the maintenance of IL-12R beta 2 chain expression and signaling.

Authors:  Ryuta Nishikomori; Takashi Usui; Chang-Yu Wu; Akio Morinobu; John J O'Shea; Warren Strober
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

3.  Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells.

Authors:  W E Thierfelder; J M van Deursen; K Yamamoto; R A Tripp; S R Sarawar; R T Carson; M Y Sangster; D A Vignali; P C Doherty; G C Grosveld; J N Ihle
Journal:  Nature       Date:  1996-07-11       Impact factor: 49.962

4.  Interleukin 12 immunotherapy after autologous stem cell transplantation for hematological malignancies.

Authors:  Michael J Robertson; David Pelloso; Rafat Abonour; Robert A Hromas; Robert P Nelson; Lisa Wood; Kenneth Cornetta
Journal:  Clin Cancer Res       Date:  2002-11       Impact factor: 12.531

5.  Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection.

Authors:  Khuong B Nguyen; Wendy T Watford; Rachelle Salomon; Sigrun R Hofmann; Gary C Pien; Akio Morinobu; Massimo Gadina; John J O'Shea; Christine A Biron
Journal:  Science       Date:  2002-09-20       Impact factor: 47.728

6.  Signal transducer and activator of transcription 4 is required for the transcription factor T-bet to promote T helper 1 cell-fate determination.

Authors:  Vivian T Thieu; Qing Yu; Hua-Chen Chang; Norman Yeh; Evelyn T Nguyen; Sarita Sehra; Mark H Kaplan
Journal:  Immunity       Date:  2008-11-14       Impact factor: 31.745

7.  Distinct requirements for the naturally occurring splice forms Stat4alpha and Stat4beta in IL-12 responses.

Authors:  Timothy Hoey; Shangming Zhang; Nathan Schmidt; Qing Yu; Shyam Ramchandani; Xiang Xu; Lisa K Naeger; Ya-Lin Sun; Mark H Kaplan
Journal:  EMBO J       Date:  2003-08-15       Impact factor: 11.598

8.  STAT4 serine phosphorylation is critical for IL-12-induced IFN-gamma production but not for cell proliferation.

Authors:  Akio Morinobu; Massimo Gadina; Warren Strober; Roberta Visconti; Albert Fornace; Cristina Montagna; Gerald M Feldman; Ryuta Nishikomori; John J O'Shea
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-04       Impact factor: 11.205

9.  STAT4 requires the N-terminal domain for efficient phosphorylation.

Authors:  Hua-Chen Chang; Shangming Zhang; India Oldham; Lisa Naeger; Timothy Hoey; Mark H Kaplan
Journal:  J Biol Chem       Date:  2003-06-12       Impact factor: 5.157

10.  Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4.

Authors:  N G Jacobson; S J Szabo; R M Weber-Nordt; Z Zhong; R D Schreiber; J E Darnell; K M Murphy
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

View more
  21 in total

1.  STAT4 is required for IL-23 responsiveness in Th17 memory cells and NKT cells.

Authors:  Nicole L Glosson-Byers; Sarita Sehra; Mark H Kaplan
Journal:  JAKSTAT       Date:  2014-10-30

2.  Simian Immunodeficiency Virus Targeting of CXCR3+ CD4+ T Cells in Secondary Lymphoid Organs Is Associated with Robust CXCL10 Expression in Monocyte/Macrophage Subsets.

Authors:  Masayuki Fujino; Hirotaka Sato; Tomotaka Okamura; Akihiko Uda; Satoshi Takeda; Nursarat Ahmed; Shigeyuki Shichino; Teiichiro Shiino; Yohei Saito; Satoru Watanabe; Chie Sugimoto; Marcelo J Kuroda; Manabu Ato; Yoshiyuki Nagai; Shuji Izumo; Kouji Matsushima; Masaaki Miyazawa; Aftab A Ansari; Francois Villinger; Kazuyasu Mori
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

3.  Effects of interleukin-18 on natural killer cells: costimulation of activation through Fc receptors for immunoglobulin.

Authors:  Shivani Srivastava; David Pelloso; Hailin Feng; Larry Voiles; David Lewis; Zdenka Haskova; Margaret Whitacre; Stephen Trulli; Yi-Jiun Chen; John Toso; Zdenka L Jonak; Hua-Chen Chang; Michael J Robertson
Journal:  Cancer Immunol Immunother       Date:  2013-04-19       Impact factor: 6.968

4.  The natural product phyllanthusmin C enhances IFN-γ production by human NK cells through upregulation of TLR-mediated NF-κB signaling.

Authors:  Youcai Deng; Jianhong Chu; Yulin Ren; Zhijin Fan; Xiaotian Ji; Bethany Mundy-Bosse; Shunzong Yuan; Tiffany Hughes; Jianying Zhang; Baljash Cheema; Andrew T Camardo; Yong Xia; Lai-Chu Wu; Li-Shu Wang; Xiaoming He; A Douglas Kinghorn; Xiaohui Li; Michael A Caligiuri; Jianhua Yu
Journal:  J Immunol       Date:  2014-08-13       Impact factor: 5.422

5.  A Dose-escalation Study of Recombinant Human Interleukin-18 in Combination With Ofatumumab After Autologous Peripheral Blood Stem Cell Transplantation for Lymphoma.

Authors:  Michael J Robertson; Christopher W Stamatkin; David Pelloso; Jill Weisenbach; Nagendra K Prasad; Ahmad R Safa
Journal:  J Immunother       Date:  2018-04       Impact factor: 4.456

6.  A dose-escalation study of recombinant human interleukin-18 in combination with rituximab in patients with non-Hodgkin lymphoma.

Authors:  Michael J Robertson; Justin Kline; Herbert Struemper; Kevin M Koch; John W Bauman; Olivia S Gardner; Sharon C Murray; Fiona Germaschewski; Jill Weisenbach; Zdenka Jonak; John F Toso
Journal:  J Immunother       Date:  2013 Jul-Aug       Impact factor: 4.456

7.  STAT4 contributes to adipose tissue inflammation and atherosclerosis.

Authors:  A D Dobrian; M A Hatcher; J J Brotman; E V Galkina; P Taghavie-Moghadam; H Pei; B A Haynes; J L Nadler
Journal:  J Endocrinol       Date:  2015-08-18       Impact factor: 4.286

8.  Evidence for STAT4 as a common autoimmune gene: rs7574865 is associated with colonic Crohn's disease and early disease onset.

Authors:  Jürgen Glas; Julia Seiderer; Melinda Nagy; Christoph Fries; Florian Beigel; Maria Weidinger; Simone Pfennig; Wolfram Klein; Jörg T Epplen; Peter Lohse; Matthias Folwaczny; Burkhard Göke; Thomas Ochsenkühn; Julia Diegelmann; Bertram Müller-Myhsok; Darina Roeske; Stephan Brand
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

Review 9.  STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors:  Hua Yu; Drew Pardoll; Richard Jove
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

10.  Polymorphisms in JAK/STAT signaling pathway genes and risk of non-Hodgkin lymphoma.

Authors:  Yingtai Chen; Qing Lan; Tongzhang Zheng; Nan Zhao; Theodore R Holford; Catherine Lerro; Min Dai; Huang Huang; Jiaxin Liang; Shuangge Ma; Brian Leaderer; Peter Boyle; Stephen Chanock; Nathaniel Rothman; Yawei Zhang
Journal:  Leuk Res       Date:  2013-06-12       Impact factor: 3.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.